Site last updated:
July 2010
Cancer Services Forum currently has 713 registered members
New cancer medicines: Joint working between the NHS and the pharmaceutical industry
Share
In developing the agenda for the meeting, my aim was to encourage debate and provide an opportunity to explore controversial issues, hopefully highlighting opportunities for improved joint working, which I have no doubt will ultimately benefit the patient.
As I said on the day, we are all NHS patients whether we work for the industry or the NHS, and at some point cancer will touch the lives of ourselves or those in our family, so it is an important issue to tackle. Here, I provide a brief overview of the meeting, with links to the slides presented on the day for those who want to explore further.
Please click here to view Mr Steve Williamson’s slides
Please click on the following session headings:
NHS perspective on individual funding requests (IFRs)
Industry perspective: UK oncology market
Drug pricing in the UK: Are risk-share schemes here to stay?
Future challenges for access to new cancer medicines
Page 2 of 14
Discussion.